PLSE · Pulse Biosciences, Inc.
$34.56
-0.91 (-2.57%)
At close · Jul 29
Market Cap
$2.45B
Shares
69.21M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$350K
FY2025
Net Income
-$72.78M
-35.8%
FY2025
Gross Margin
-54%
FY2025
Operating Margin
-21982.57%
FY2025
Operating Cash Flow
-$54.12M
-48.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $751K | $350K | $0 | $0 | $700K | $1.42M | $0 | — | — | — | — | — | |
| -$616K | — | — | — | — | — | $114K | $983K | $418K | $247K | $68K | — | |
| — | $539K | $0 | $0 | $11.94M | $1.97M | $0 | $600K | $600K | $800K | $500K | — | |
| — | -$189K | $0 | $0 | -$11.24M | -$550K | $0 | — | — | — | — | — | |
| — | -54% | — | — | -1606.29% | -38.79% | — | — | — | — | — | — | |
| $47M | $44.72M | $32.34M | $27.8M | $20.84M | $28.64M | $26.44M | $24.96M | $17.25M | $9.65M | $5.51M | $2.18M | |
| $31.47M | — | $23.92M | $15.78M | $13.96M | $19.07M | $16.27M | $17.14M | $20.05M | $15.5M | $3.42M | $1.62M | |
| — | $32.03M | $23.92M | — | — | — | — | — | — | — | — | — | |
| — | $665K | $666K | $665K | $665K | $666K | $665K | $666K | $665K | $665K | $665K | $666K | |
| $59.99M | — | — | — | — | — | $49.97M | $47.95M | $37.96M | $25.81M | $9.59M | $4.47M | |
| $78.8M | $77.29M | $56.26M | $43.57M | $58.76M | $64.43M | $49.97M | $47.95M | — | — | — | — | |
| -$78.05M | -$76.94M | -$56.26M | -$43.57M | -$58.06M | -$63.01M | -$49.97M | -$47.95M | -$37.55M | -$25.57M | -$9.52M | -$4.47M | |
| — | -21982.57% | — | — | -8293.86% | -4443.86% | — | — | — | — | — | — | |
| $3.48M | $4.16M | $2.67M | $1.36M | -$448K | -$646K | $114K | $983K | — | — | — | — | |
| — | $72.8M | $53.6M | -$42.21M | -$58.51M | -$63.66M | -$49.85M | -$46.97M | -$37.55M | — | — | — | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | -$23K | -$1.66M | |
| -$74.57M | -$72.78M | -$53.59M | -$42.21M | -$58.51M | -$63.66M | -$49.85M | -$46.97M | -$37.55M | -$25.57M | -$9.52M | -$2.81M | |
| — | -20794.57% | — | — | -8357.86% | -4489.42% | — | — | — | — | — | — | |
| -$74.57M | -$72.78M | -$53.59M | -$42.21M | -$58.51M | -$63.66M | -$49.86M | -$46.97M | -$37.5M | -$25.61M | -$9.53M | -$2.81M | |
| USD/shares | — | -$1.08 | -$0.92 | -$0.85 | -$1.72 | -$2.28 | -$2.14 | — | — | — | — | — |
| shares | — | 67.4M | 58.4M | 49.74M | 33.94M | 27.96M | 23.25M | 20.75M | 17.08M | 14.75M | 11.01M | 7.57M |
| shares | — | — | — | — | — | 27.96M | 23.25M | 20.75M | 17.08M | 14.75M | 11.01M | 7.57M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 3.14×
EV/EBIT
—
Peer median 33.90×
P/E (TTM)
—
Peer median 43.15×
Peer medians compare against the 26 similar-size Medical Instruments & Supplies companies (of 50 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| North America | $517,000 | $1,182,000 | $0 |
| Rest of World | $183,000 | $236,000 | $0 |
By Product & Service (USD)
| Component | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| System Products | $560,000 | $1,189,000 | $0 |
| Cycle Units Products | $140,000 | $229,000 | $0 |
| Systems Products | — | $1,189,000 | — |
| Product | — | $1,418,000 | $0 |
Key facts
CIK
1625101
CUSIP
74587B101
13F (30d)
13 filings
13 filers
Visit website
Investor relations